China Telemedicine Market Analysis Report 2022 to 2030

China Telemedicine Market Analysis

$ 3999

China's telemedicine market size is at around $4.88 Bn in 2022 and is projected to reach $20.6 Bn in 2030, exhibiting a CAGR of 19.7% during the forecast period 2022-2030. China's Telemedicine Market is segmented by component, modality, delivery mode, and facility. Changes in healthcare insurance coverage and restrictions have a substantial impact on people's out-of-pocket expenses, which fuels the Chinese telemedicine market's demand. Some of the top players are Ping An Healthcare & Technology Co., Alibaba Health Information Technology Ltd., JD Health International Inc., and Medix.

ID: IN10CNDH010 CATEGORY: Digital Health GEOGRAPHY: China

Buy Now

China Telemedicine Market Analysis Summary

China's telemedicine market size is at around $4.88 Bn in 2022 and is projected to reach $20.6 Bn in 2030, exhibiting a CAGR of 19.7% during the forecast period. The percentage of GDP devoted to healthcare in China in 2021 was down from 7.1% the year before to approximately 6.7%. In terms of relative numbers, health spending as a percentage of GDP has been rising over the past 20 years and has recently surpassed 6%. The National Health Commission reports that there are currently 6.7 medical beds per 1,000 people in China, and there are less than 4 intensive care units (ICU) per 100,000 people, indicating a serious disparity between the number of patients and available medical resources.

The COVID-19 situation at the start of 2020 explains why the 2% increase in the penetration rate of telemedicine year over year was expected. By April 2019, there were 45 Mn active users of online telemedicine services in China, with a 6.6% market penetration rate. The potential demand for telemedicine in the central and western regions is enormous because more than 70% of third-level grade-A hospitals are situated in the eastern region.

China Telemedicine Market Analysis

Market Dynamics

Market Growth Drivers Analysis

In China, telemedicine began relatively late, but with the help of 5G technology and the COVID-19 scenario, its applications have grown to include remote ultrasound, remote surgery, and even remote first aid. According to the National Health Commission, China now has less than 4 intensive care units (ICU) per 100,000 people and only 6.7 hospital beds per 1,000 people, indicating a significant imbalance between the number of patients and the available medical resources. This factor plays an important factor in the growth of the telemedicine market in the country. In China, the market for online healthcare was dominated in 2021 by online pharmacies and digital healthcare infrastructure.

Market Restraints

Changes in healthcare insurance coverage and rules have a significant impact on individuals' out-of-pocket expenses. This could result in differences in services and have an effect on the standard of care.

Patients frequently have to pay out of cash due to differences in coverage between and between federal and private payers. Before co-insurance kicks in, patients can be responsible for a co-pay, co-insurance, facility fees, and reaching a large deductible. As the majority of these services are not covered by health insurance, this may discourage people from choosing telemedicine services.

Competitive Landscape

Key Players

Ping An Good Doctor (Ping An Healthcare & Technology Co.) (CHN)
Alibaba Health Information Technology Ltd. (CHN)
JD Health International Inc. (CHN)
Medix (CHN)
AliHealth (CHN)
WeDoctor (Tencent)
Intco Medical Technology

Notable Recent Updates

December 2022: To provide 24-hour medical consultations, JD Health launched its "online anti-COVID clinic." The telemedicine service is anticipated to offer people the much-needed support they need to cope with the rise in infections, with an average response time of less than 30 seconds.

January 2022: The digital healthcare company, ETAO International Group, will be valued at $2.5 Bn after merging with a blank-check business and going public. Healthcare services from ETAO, including hospital and primary care, health insurance, pharmacies, and telemedicine, are offered both online and offline in China.

Healthcare Policies and Regulatory Landscape

The three main enforcement priorities in relation to digital health are personal information protection, data security, and cybersecurity. China has established the Personal Information Protection Law, the Data Security Law, and the Cybersecurity Law, all of which went into effect on November 1, 2021. The Multi-Level Protection Scheme ("MLPs") implemented in the field of cybersecurity has become a main focus in enforcement in most industries, including digital health. MLPs are an obligatory legal requirement stipulated by the Cybersecurity Law and pertinent regulations. The National Health Commission – Internet-based diagnosis and treatment and remote consultations between healthcare institutions are regulated by the NHC. The National Medical Products Administration ("NMPA”): The NMPA regulates drugs, medical devices, and cosmetics, and is responsible for the safety, supervision, and management of standard formulation, registration, manufacturing, and post-market risk management.

Reimbursement Scenario

Basic Medical Insurance (BMI) serves as the foundation and medical aid serves as the backup for China's multilevel national medical security system. Commercial health insurance, charitable contributions, and medical mutual aid activities serve as supplemental services. The cost of telemedicine services is currently not covered by the state's medical insurance, but it is anticipated that in the future these costs will be covered by the state's medical insurance. Since it is challenging to determine and standardize the prices of different telemedicine services offered throughout the nation and since the majority of these services are not covered by health insurance, this may discourage people from choosing telemedicine services.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Telemedicine Market Segmentation

Component

Product
- Hardware
- Software
- Others
Services
- Tele-consulting
- Tele-monitoring
- Tele-education

Modality

The industry is driven by three concepts, which include real-time (synchronous), store and forward (asynchronous), and others comprising remote patient monitoring, etc.

Store and forward
Real-time
Others

Application

Teleradiology
Telepsychiatry
Telepathology
Teledermatology
Telecardiology
Others

Delivery Mode

Web/Mobile
Audio/Text-based
Visualized
Call centers

Facility

Tele-hospital
Tele-home

End-user

Providers
Payers
Patients
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.